In The News
Protecting the Health and Safety of all Americans
MedWatch - The FDA Safety Information and Adverse Event Reporting Program
- Losartan Potassium Tablets and Losartan Potassium/Hydrochlorothiazide Tablets by Torrent Pharmaceuticals Limited: Recall - Due to the Detection of Trace Amounts of N-Methylnitrosobutyric Acid Found in an Active Pharmaceutical Ingredient (API) (03/01/19)
- Amlodipine Valsartan Tablets and Valsartan Tablets by AurobindoPharma USA: Recall - Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity (03/01/19)
- Losartan Potassium Tablets by Camber Pharmaceuticals: Recall - Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino Butyric Acid (NMBA) Impurity Found in the API (02/28/19)
NIH study of brain energy patterns provides new insights into alcohol effects
Study could help understanding of how the brain uses energy in health and disease.
What's New at AHRQ
AHRQ Views—Blog: Step by Step, Improving Heart Health in America
Long periods of sedentary behavior may increase cardiovascular risk in older women
new study has found that the longer older women sit or lay down during the course of a day—and the longer the individual periods of uninterrupted sitting—the greater their risk of cardiovascular diseases such as heart disease and stroke. But...
Monthly buprenorphine injections effective for opioid use disorders
Study results on long-acting injection formulation now published.
Two decades of data reveal overall increase in pain, opioid use among U.S. adults
Researchers measured pain’s impact on normal work activities, people’s health status, and health care use.
Study helps solve mystery of how sleep protects against heart disease
Addressing Social Isolation To Improve the Health of Older Adults: A Rapid Review
Purpose of Review
To rapidly evaluate the effect of interventions targeting social isolation/loneliness in community-dwelling older adults (60 years and older) on outcomes of social isolation/loneliness, health and health care utilization.
NIH study provides answer to long-held debate on blood sugar control after stroke
Findings may have immediate impact on clinical practice.